Search details
1.
Cyclosporine A in hospitalized COVID-19 pneumonia patients to prevent the development of interstitial lung disease: a pilot randomized clinical trial.
Sci Rep
; 14(1): 3789, 2024 02 15.
Article
in English
| MEDLINE | ID: mdl-38360855
2.
[New strategies in the optimisation of lopinavir/ritonavir doses in human immunodeficiency virus-infected patients]. / Nuevas estrategias en la optimización posológica de lopinavir/ritonavir en pacientes infectados por el virus de la inmunodeficiencia humana.
Enferm Infecc Microbiol Clin
; 31(1): 36-43, 2013 Jan.
Article
in Spanish
| MEDLINE | ID: mdl-22280562
3.
Population pharmacokinetics of lopinavir/ritonavir (Kaletra) in HIV-infected patients.
Ther Drug Monit
; 33(5): 573-82, 2011 Oct.
Article
in English
| MEDLINE | ID: mdl-21912331
4.
Individualized Protease Inhibitor Monotherapy: The Role of Pharmacokinetics and Pharmacogenetics in an Aged and Heavily Treated HIV-Infected Patient.
Clin Drug Investig
; 39(11): 1125-1131, 2019 Nov.
Article
in English
| MEDLINE | ID: mdl-31401737
5.
CYP3A4 polymorphism and lopinavir toxicity in an HIV-infected pregnant woman.
Clin Drug Investig
; 35(1): 61-6, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25391550
6.
Population pharmacokinetic/pharmacogenetic model of lopinavir/ritonavir in HIV-infected patients.
Per Med
; 11(7): 693-704, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-29764054
Results
1 -
6
de 6
1
Next >
>>